These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4790565)

  • 21. Susceptibility-resistance pattern of Neisseria meningitidis isolated in the province of Ontario, Canada.
    Shtibel R
    Ann Microbiol (Paris); 1979 Jul; 130B(1):3-11. PubMed ID: 159654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method to determine antibacterial activity of silver sulfadiazine creams.
    Klein S; Lentsch RH; Christoffersen G
    J Burn Care Rehabil; 1986; 7(5):382-4. PubMed ID: 3095328
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo activities of sitafloxacin against Chlamydia spp.
    Miyashita N; Niki Y; Matsushima T
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3270-2. PubMed ID: 11600398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The determination of the susceptibility of bacterial isolates to silver sulfadiazine.
    Rosenkranz HS; Carr HS
    Chemotherapy; 1978; 24(3):143-5. PubMed ID: 657875
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of Veterinary-Specific Interpretive Criteria for Susceptibility Testing of Streptococcus equi Subspecies with Trimethoprim-Sulfamethoxazole and Trimethoprim-Sulfadiazine.
    Sadaka C; Kanellos T; Guardabassi L; Boucher J; Watts JL
    J Clin Microbiol; 2017 Jan; 55(1):326-330. PubMed ID: 27847375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine.
    LOVE BD; FINLAND M
    Am J Med Sci; 1954 Nov; 228(5):534-9. PubMed ID: 13207113
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquisition and synthesis of folates by obligate intracellular bacteria of the genus Chlamydia.
    Fan H; Brunham RC; McClarty G
    J Clin Invest; 1992 Nov; 90(5):1803-11. PubMed ID: 1430206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties and frequency of isolation of chlamydiae from eyes of lambs with conjunctivitis and polyarthritis.
    Stephenson EH; Storz J; Hopkins JB
    Am J Vet Res; 1974 Feb; 35(2):177-80. PubMed ID: 4813318
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility of Neisseria meningitidis strains from the civilian population to sulfadiazine, penicillin, and rifampin.
    Wiggins GL; McLaughlin JV; Bickham ST; Jones WL; Balows A
    Appl Microbiol; 1970 Dec; 20(6):893-8. PubMed ID: 4992654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of antibiotic susceptibility of Rickettsiae and Chlamydiae in BS-C-1 cell cultures.
    Barker LF
    Antimicrob Agents Chemother (Bethesda); 1968; 8():425-8. PubMed ID: 4980837
    [No Abstract]   [Full Text] [Related]  

  • 33. The effector of antibiotics on the Chlamydia family.
    Orfila J; Laurans G
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (1):7-82. PubMed ID: 7178707
    [No Abstract]   [Full Text] [Related]  

  • 34. [In vitro antibacterial activity of the trimethoprim/sulfadiazine combination].
    Russo G; Geraci C; Stefani S; Toscano MA; Mezzatesta M; Nicoletti G
    G Ital Chemioter; 1985; 32(1):211-5. PubMed ID: 3830781
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG; Melton ML
    J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology of Chlamydia.
    Bergan T
    Scand J Infect Dis Suppl; 1982; 32():11-5. PubMed ID: 6958006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of rifampin-resistance in Chlamydia trachomatis.
    Keshishyan H; Hanna L; Jawetz E
    Nature; 1973 Jul; 244(5412):173-4. PubMed ID: 4583501
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative investigation in vitro of the sensibility of atypical mycobacteria to cycloserine and to other antibacterial substances.
    Gernez-Rieux C; Devulder B
    Scand J Respir Dis Suppl; 1970; 71():22-34. PubMed ID: 5271991
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides.
    Restrepo A; Arango MD
    Antimicrob Agents Chemother; 1980 Jul; 18(1):190-4. PubMed ID: 7416744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.